Tirzepatide Prices for Research - Pharmaceutical Grade Peptide 60mg

Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This peptide mimics the action of endogenous incretins to enhance insulin secretion, suppress glucagon levels, delay gastric emptying, and reduce appetite, making it valuable for metabolic research.

The compound features a 39-amino acid peptide backbone with two non-natural residues (Aib at positions 2 and 13) and a C20 fatty diacid side chain at Lys20, contributing to its extended half-life of approximately 117 hours. These structural characteristics make it particularly interesting for long-term metabolic studies.

For research purposes, tirzepatide is typically administered in controlled dosages. The initial research dose is often 2.5 mg administered subcutaneously, with potential escalation to 5 mg after 4 weeks. Subsequent increments of 2.5 mg may be implemented every 4 weeks based on study requirements, with a maximum research dose of 15 mg.

Our tirzepatide is supplied as a freeze-dried powder with 99% purity, available in various research quantities from 5mg to 60mg vials. The product undergoes rigorous quality control including HPLC and mass spectrometry analysis to ensure consistency and purity for research applications.

Note: This product is intended for research use only, not for human consumption. Researchers should follow all applicable guidelines and regulations when working with this compound.